Appendix from Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib As First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma
openalex(2023)
Key words
Renal Cell Carcinoma,Treatment
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined